Alexion Pharma (ALXN) Offering Possible 18.34% Return Over the Next 17 Calendar Days

This post was originally published on this site

Alexion Pharma’s most recent trend suggests a bullish bias. One trading opportunity on Alexion Pharma is a Bull Put Spread using a strike $165.00 short put and a strike $155.00 long put offers a potential 18.34% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $165.00 by expiration. The full premium credit of $1.55 would be kept by the premium seller. The risk of $8.45 would be incurred if the stock dropped below the $155.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Alexion Pharma is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Alexion Pharma is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Alexion Pharma

Alexion Pharmaceuticals (ALXN) Beats Q1 Earnings and Revenue Estimates
Fri, 30 Apr 2021 16:25:04 +0000
Alexion (ALXN) delivered earnings and revenue surprises of 14.29% and 4.49%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track
Fri, 30 Apr 2021 14:28:02 +0000
Alexion (ALXN) tops earnings and sales in the first quarter of 2021. Its merger with AstraZeneca is expected to close in the third quarter.

Alexion Reports First Quarter 2021 Results
Fri, 30 Apr 2021 12:00:00 +0000
Alexion Reports First Quarter 2021 Results

UPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021
Wed, 28 Apr 2021 21:00:00 +0000
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2021 before the US financial markets open on April 30, 2021, rather than on May 3, 2021 as previously announced.

Analysts Estimate Alexion Pharmaceuticals (ALXN) to Report a Decline in Earnings: What to Look Out for
Mon, 26 Apr 2021 16:31:04 +0000
Alexion (ALXN) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Be Sociable, Share!

Related Posts